75 Percent of Farmers Are Open to Innovation to Cope With Climate Change, Global Research Reveals
27 September 2024, Germany: 75 percent of farmers are already impacted by climate change or worried about its impacts, and 71 percent
Read MoreFind the latest news, research, product launches, financial results, investments, partnerships, regulatory developments, and business updates from Bayer. Stay informed on Crop Science, pharmaceuticals, consumer health, crop protection, seeds, biologicals, digital agriculture, healthcare, sustainability, and global business developments.
Bayer AG is a global life science company headquartered in Leverkusen, Germany, operating through three divisions: Crop Science, Pharmaceuticals, and Consumer Health. Its businesses develop products and technologies across agriculture and healthcare, with the company focused on addressing challenges related to food security, climate change, disease prevention, and healthcare access. Bayer’s global portfolio includes seeds, biotechnology traits, crop protection products, digital agriculture solutions, prescription medicines, and consumer healthcare brands.
The Crop Science division is particularly relevant to agriculture, with activities spanning seeds and traits, herbicides, fungicides, insecticides, biologicals, digital farming, and agricultural research. Bayer is advancing a pipeline of new agricultural products while focusing on technologies designed to improve farm productivity, resource efficiency, and resilience. Its current agricultural strategy includes a portfolio of ten planned blockbuster launches.
In India, Bayer has been present for more than 130 years and operates through businesses including Crop Science, Pharmaceuticals and Consumer Health. Bayer CropScience Limited is the group’s listed Indian Crop Science company, with activities covering crop protection, seeds, traits, biologicals and digital farming. The India Crop Science business works with more than 30 million smallholder farmers and focuses on crops including rice, corn, cotton, fruits and vegetables.
Bayer’s global developments in 2026 include Crop Science innovation, financial performance, product pipeline advancement, agricultural technology, sustainability, glyphosate litigation, and strategic investments. The company reported higher Crop Science sales and substantial earnings growth in both the first and second quarters of 2026.
This category features Bayer news, Crop Science, Bayer CropScience India, crop protection, seeds, herbicides, fungicides, insecticides, biologicals, digital agriculture, product launches, R&D, financial results, regulatory developments, sustainability, glyphosate, leadership, investments, partnerships, and global agriculture and healthcare developments.
27 September 2024, Germany: 75 percent of farmers are already impacted by climate change or worried about its impacts, and 71 percent
Read MoreNew operating model means Bayer teams can respond more quickly to farmers’ needs, providing personalized solutions to help them increase
Read More07 August 2024, Leverkusen: The Bayer Group generated increased sales and lower earnings in the second quarter of 2024. Each business delivered
Read More23 July 2024, AU: It’s not every day that you get the chance to celebrate a colleague’s 50th year at the same
Read More18 June 2024, USA: Bayer aims to launch ten blockbuster products in the next ten years to support farmers worldwide, the company
Read More06 June 2024, Australia: At Bayer, we are proud that the majority of our crop protection products we sell in Australia are
Read More28 May 2024, Monheim: As part of its strategic open innovation approach global life science company Bayer has advanced two initiatives with
Read More27 April 2024, New Delhi: Bayer, a global enterprise with core competencies in the life science fields of healthcare and agriculture, announced
Read More26 April 2024, Leverkusen: In 2023, the Bayer Group’s three divisions asserted themselves, and in some core areas, outperformed their peers. “That’s
Read More23 April 2024, Germany: Bayer announced today that it has signed an agreement with UK-based company AlphaBio Control to secure an exclusive
Read More